Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis
Open Access
- 1 January 1976
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 19 (1), 115-118
- https://doi.org/10.1002/art.1780190121
Abstract
Simultaneous measurements of serum salicylate, SGPT, and SGOT concentrations were made on 92 children receiving salicylates for arthritis during a 13‐month period. Statistical correlations were found between salicylate and transaminase concentrations in patients with juvenile rheumatoid arthritis when in active stages. However elevated transaminase levels occurred with low salicylate levels and during inactive stages, and were inconstant in individual patients. Marked transaminase abnormalities were transient and appeared unpredictably in individual patients. Some factor in addition to salicylate concentration must be involved in raising serum transaminase levels. No evidence of chronic hepatotoxicity was noted.This publication has 15 references indexed in Scilit:
- Aspirin HepatotoxicityAnnals of Internal Medicine, 1974
- Aspirin HepatitisAnnals of Internal Medicine, 1974
- Aspirin-Induced Hepatic InjuryAnnals of Internal Medicine, 1974
- Aspirin-Induced Hepatotoxicity in Patients with Systemic Lupus ErythematosusAnnals of Internal Medicine, 1974
- Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritisArthritis & Rheumatism, 1973
- Serum transaminases and salicylate therapy.BMJ, 1972
- Acute hepatic dysfunction in juvenile rheumatoid arthritisThe Journal of Pediatrics, 1971
- Serum Transaminases during Salicylate TherapyBMJ, 1971
- Hepatic involvement in juvenile rheumatoid arthritisThe Journal of Pediatrics, 1970
- Effect of Salicylate on the Activity of Plasma Enzymes in the RabbitNature, 1960